MMC
60
6
CRM
65
6
FTI
76
3
AA
60
9
DLTR
38
4
USB
61
11
MCD
50
-2
AVB
64
4
NRG
52
3
C
60
2
AMG
52
2
VRSK
77
4
URI
60
7
SBUX
39
3
HRL
41
2
STI
31
-16
FITB
60
2
FLR
55
6
AFL
49
3
URBN
42
4
MMC
60
6
CRM
65
6
FTI
76
3
AA
60
9
DLTR
38
4
USB
61
11
MCD
50
-2
AVB
64
4
NRG
52
3
C
60
2
AMG
52
2
VRSK
77
4
URI
60
7
SBUX
39
3
HRL
41
2
STI
31
-16
FITB
60
2
FLR
55
6
AFL
49
3
URBN
42
4
Financhill
Back

Repligen Vs. Perspective Therapeutics Industry Stock Comparison

Sell
48

RGEN
Repligen

Last Price:
141.70
Seasonality Move:
11.98%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Sell
48
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $141.76. The Score for RGEN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $141.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 52.33 Buy
Chaikin Money Flow: 577126 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (132.45 - 146.27) Buy
Bollinger Bands (100): (130.51 - 153.71) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 137.34 Buy
20-day SMA: 138.56 Buy
50-day SMA: 140.21 Buy
200-day SMA: 156.32 Sell
8-day EMA: 136.81 Buy
20-day EMA: 138.37 Buy
50-day EMA: 140.49 Buy
200-day EMA: 150.59 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):